The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers

FASEB J. 2022 Oct;36(10):e22509. doi: 10.1096/fj.202200844R.

Abstract

Semaphorins (Semas), which belongs to the axonal guidance molecules, include 8 classes and could affect axon growth in the nervous system. Recently, semaphorins were found to regulate other pathophysiological processes, such as immune response, oncogenesis, tumor angiogenesis, and bone homeostasis, through binding with their plexin and neuropilin receptors. In this review, we summarized the detailed role of semaphorins and their receptors in the pathological progression of various cardiovascular diseases (CVDs), highlighting that semaphorins may be potential therapeutic targets and novel biomarkers for CVDs.

Keywords: axonal guidance molecule; cardiovascular diseases; neuropilin; plexin; semaphorin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Cardiovascular Diseases*
  • Cell Transformation, Neoplastic
  • Humans
  • Neovascularization, Pathologic / pathology
  • Semaphorins* / metabolism

Substances

  • Biomarkers
  • Semaphorins